PROVIDER PROFILE · NPI 1942275748

Recaredo BerbanoMD

Internal MedicineNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$28K

Distinct drugs

Brand share

100.0%

Top prescribed drugs

Metformin Hcl39 claims

Semaglutide31 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

REFERRAL NETWORK

Where Recaredo Berbano's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 75 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
WILKES BARRE HOSPITAL COMPANY LLC	546	2,302
CANSECO-BERBANO, RACHEL	141	193
RICHTERMAN, RONALD	112	218
GEISINGER WYOMING VALLEY MEDICAL CENTER	100	316
ACCUVANCE DIAGNOSTICS CORPORATION	91	259
Guenadi Amoachi Diagnostic Radiology · Wilkes Barre, PA	87	140
Gil Hoang Diagnostic Radiology · Dover, DE	79	126
Satish Patel Diagnostic Radiology · Wilkes Barre, PA	59	113
Michael Rupp Interventional Cardiology · Wilkes Barre, PA	49	110
John Ellis Cardiology · Plains, PA	47	101
Farook Shroff Cardiology · Wilkes Barre, PA	44	97
Alysha Davis Physician Assistant · Kingston, PA	42	128

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history